Stress deficiency of the T-lymphocyte system exemplified by Down syndrome

Lancet. 1977 Jan 22;1(8004):163-6. doi: 10.1016/s0140-6736(77)91763-9.

Abstract

A comparison of immune competence in 26 patients with Down syndrome in an institution and 26 matched healthy controls revealed an atypical pattern of T-cell immunodeficiency in the Down-syndrome patients. The patients with Down syndrome had a lymphocytosis in blood with high counts of T (and B) cells, but with impaired effector function of T cells as judged by anergy to dinitrochlorobenzene, low responsiveness to ubiquitous antigens which elicit delayed-type hypersensitivity reactions, and low mitogenic activity of non-stimulated and phytohaemagglutinin-stimulated lymphocytes in culture. Helper-T-cell function measured by the humoral immune response to flagellin was intact, and there were minor abnormalities of the B-cell system. Attempted restoration of T-cell function with levamisole was unsuccessful. This pattern of T-lymphocytosis with impaired effector function could be explained by "stress-deficiency" of the immune system consequent upon a heavy load of infection in early life.

MeSH terms

  • Adolescent
  • Adult
  • Autoantibodies / isolation & purification
  • B-Lymphocytes / pathology
  • Down Syndrome / immunology*
  • Female
  • Humans
  • Immunoglobulins / analysis
  • Immunologic Deficiency Syndromes / diagnosis
  • Immunologic Deficiency Syndromes / drug therapy
  • Immunologic Deficiency Syndromes / etiology*
  • Immunologic Techniques
  • Leukocyte Count
  • Levamisole / therapeutic use
  • Lymphocytosis / blood
  • Lymphocytosis / etiology
  • Male
  • Middle Aged
  • Placebos
  • Stress, Physiological / complications
  • Stress, Physiological / immunology*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology

Substances

  • Autoantibodies
  • Immunoglobulins
  • Placebos
  • Levamisole